Reneo Pharmaceuticals (RPHM) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Reneo Pharmaceuticals, Inc. is pushing forward with cost-cutting measures by planning a 20% workforce reduction by the end of February 2024. This move is anticipated to cost the company around $1.7 million in severance and related expenses in the early part of the year. However, these figures are based on preliminary assumptions and the actual costs could significantly vary. Additional unforeseen expenses may also arise during the process of this downsizing initiative.
For further insights into RPHM stock, check out TipRanks’ Stock Analysis page.